IL-22+CD4+ T cells in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 16, Issue 5, 2013, Pages 518-526

  Zhao, Ling ^a   Jiang, Zhenyu ^a   Jiang, Yanfang ^a   Ma, Ning ^a   Zhang, Yandong ^a   Feng, Li ^a   Wang, Kai ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

IL 22; Rheumatoid arthritis; Th1; Th17; Th22

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL;

IL-22; RHEUMATOID ARTHRITIS; TH1; TH17; TH22;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHINA; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; SEVERITY OF ILLNESS INDEX; TH17 CELLS;

EID: 84886592682     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12099     Document Type: Article

References (28)

1. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38, 151-60.
2. Miossec P (2004) An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16, 218-22.
3. +T lymphocytes. Cell Res 16, 902-7.
4. +T cell function via L-arginine metabolism. Cancer Res 69, 3086-94.
5. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct fromT(H) 17, T(H)1 and T(H)2 cells. Nat Immunol 10, 864-87.
6. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H (2002) The interleukin-10 family of cytokines. Trends Immunol 23, 89-96.
7. Wolk K, Witte E, Wallace E et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36, 1309-23.
8. Aujla SJ, Kolls JK (2009) IL-22: a critical mediator in mucosal host defense. J Mol Med 87, 451-4.
9. Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17, 367-80.
10. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R (2004) IL-22 increases the innate immunity of tissues. Immunity 21, 241-54.
11. Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, Fabbri P (2009) Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 29, 210-4.
12. Brand S, Beigel F, Olszak T et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290, G827-38.
13. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. (2005) Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52, 1037-46.
14. Zhang L, Li JM, Liu XG et al. (2011) Elevated Th22 cells Correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 31, 606-14.
15. Witte E, Witte K, Warszawska K, Sabat R, Wolk K (2010) Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 21, 365-79.
16. Eyerich S, Eyerich K, Pennino D et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119, 3573-85.
17. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10, 857-63.
18. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130, 1373-83.
19. Raza K, Falciani F, Curnow SJ et al. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7, R784-95.
20. Ziolkowska M, Koc A, Luszczykiewicz G et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitroI L-17 production via cyclosporinA -sensitive mechanism. J Immunol 164, 2832-8.
21. Smolen JS, Tohidast-Akrad M, Gal A et al. (1996) The role of T lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol 25, 1-4.
22. Kawashima M, Miossec P (2005) mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity. J Clin Immunol 25, 209-14.
23. Shen H, Goodall JC, Hill Gaston JS (2009) Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60, 1647-56.
24. Arnett FC, Edworthy SM, Bloch DA et al. (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
25. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-8.
26. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC (2002) Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10. J Biol Chem 277, 33676-82.
27. Schmechel S, Konrad A, Diegelmann J et al. (2008) Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflam Bowel Dis 14, 204-12.
28. Volpe E, Servant N, Zollinger R et al. (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9, 650-7.